Research finds organs exhibit varying biological aging rates using AI analysis — Evidence Review
Published in Nature Medicine, by researchers from CeMM Research Center for Molecular Medicine, Ludwig Boltzmann Institute for Network Medicine, University of Vienna
Researched by
— the AI search engine for science
Table of Contents
A new study using AI-based tissue clocks shows that human organs age at different rates, and some of these differences can be detected from blood samples. Most related research supports that biological aging is heterogeneous across tissues and can be measured beyond chronological age, aligning with the findings published in Nature Medicine.
- Multiple studies confirm that organs and systems within the same individual can follow diverse aging trajectories, and that advanced biological aging in one system predicts increased risk for disease and mortality in others 2 6 9.
- Recent research has advanced the estimation of biological age using molecular, physiological, and AI-driven approaches, with deep learning models increasingly outperforming traditional biomarkers for organ-specific predictions 5 12 13.
- Blood-based and multi-omics biomarkers, as well as machine learning models, now offer practical and accurate methods to assess biological aging and its clinical implications, supporting the approach used in this new study 6 10 13.
Study Overview and Key Findings
Understanding how different organs age is increasingly important for predicting disease risk and developing personalized interventions. This study introduces AI-driven tissue clocks that estimate the biological age of 40 different human organs using histology images, offering new insights into the variability of aging processes within the body. Notably, the research uncovers that some organ-specific aging patterns can be inferred from blood, potentially paving the way for non-invasive diagnostics.
| Property | Value |
|---|---|
| Study Year | 2026 |
| Organization | CeMM Research Center for Molecular Medicine, Ludwig Boltzmann Institute for Network Medicine, University of Vienna |
| Journal Name | Nature Medicine |
| Authors | Ernesto Abila, Iva Buljan, Yimin Zheng, Lisa Kleissl, Sigrid Klotz, Tamas Veres, Zhilong Weng, Maja Nackenhorst, Rizqah Kamies, Anja Michl, Safwen Kadri, Samir Moustafa, Wolfgang Hulla, Matthias Perkonigg, Mathias Drach, Philipp Tschandl, Barbara Sterniczky, Matthias Heinig, Laurens J. De Sadeleer, Wim Wuyts, Bart Vanaudenaerde, Laurens J. Ceulemans, Daniel D. Buchanan, Lochlan J. Fennell, Georg Stary, Yuri Tolkach, Adelheid Wöhrer, Herbert B. Schiller, André F. Rendeiro |
| Population | Human tissues from various organs |
| Sample Size | 25,712 images from 983 people |
| Outcome | Biological age of organs, aging patterns from blood |
| Results | AI-based models predicted biological age with an average error of 4.9 years. |
Literature Review: Related Studies
We searched the Consensus paper database, which contains over 200 million research papers, to identify studies relevant to biological age prediction and organ-specific aging. The following search queries were used:
| Topic | Key Findings |
|---|---|
| How variable is biological aging across organs and individuals? | - Organ and system-specific biological ages vary significantly within individuals, influencing disease risk and mortality 2 6 8 9. - Multiple studies report that faster biological aging in one organ can accelerate aging in others and is linked to earlier onset of frailty and cognitive decline 2 8. |
| How accurate and informative are current biological age predictors? | - Epigenetic clocks and multi-omics models can estimate biological age, with recent AI/machine learning models improving accuracy and interpretability 1 5 12 13. - Most predictors, except telomere length, are associated with mortality risk and health outcomes independently of chronological age 3 4 5 13. |
| Can blood-based or non-invasive markers capture organ-specific aging? | - Blood-based proteomic and metabolomic clocks can detect accelerated aging in specific organs and predict disease risk, sometimes outperforming traditional biomarkers 6 9 10 14. - Machine learning models using blood biomarkers offer practical, cost-efficient biological age estimation for clinical use 10 13. |
| What are the clinical and research implications of measuring organ-specific aging? | - Measuring organ-specific biological age may inform early interventions, disease monitoring, and health risk stratification 2 7 8 9. - Composite measures and explainable AI approaches can help untangle the mechanisms of aging, aiding clinical decision-making and research on aging interventions 7 13. |
How variable is biological aging across organs and individuals?
Research consistently demonstrates that biological aging is not uniform: organs and body systems can age at different rates within the same individual. The new study builds on this by using AI to directly measure these differences in tissue samples, revealing detailed timelines for age-related changes in various organs. Prior studies have shown that advanced aging in one system, such as the brain or cardiovascular system, can influence aging in others and is linked to increased risk of chronic diseases and mortality 2 6 8 9.
- Organ and system-specific biological ages can diverge widely within an individual, often correlating with disease risk and survival outcomes 2 6 9.
- Longitudinal cohort studies reveal that individuals with faster biological aging in midlife experience earlier cognitive and functional decline 8.
- Multi-organ aging networks suggest that age-related changes in one organ can impact the trajectory of others, underscoring the interconnectedness of biological aging 2.
- The new study's approach to visualizing tissue aging aligns with multi-omics evidence that aging clocks operate both systemically and in organ-specific ways 9.
How accurate and informative are current biological age predictors?
Traditional biological age predictors include epigenetic clocks, telomere length, and biomarker-based indices. Recent advancements have focused on machine learning and deep learning models, which use complex datasets to improve accuracy. The study's AI-based tissue clocks achieved an average error of 4.9 years, outperforming some DNA methylation-based models in tissue-specific pathology prediction. Prior research indicates that most biological age measures—except telomere length—predict mortality and health outcomes independently of chronological age 3 4 5 13.
- Epigenetic and multi-omics clocks remain widely used, but deep learning approaches offer improved accuracy and scalability 5 12 13.
- Newer models, like ENABL Age, provide interpretable biological age estimates and outperform traditional clocks in predicting mortality 13.
- The largest predictive effects for mortality are seen with methylation age estimators and frailty indices 3.
- The integration of multiple data types and AI-driven analytics is enhancing both the precision and clinical relevance of age prediction 5 12.
Can blood-based or non-invasive markers capture organ-specific aging?
A major clinical challenge is to assess organ aging without invasive procedures. The new study demonstrates that tissue-derived aging signatures can be mirrored in blood-based gene expression profiles. This is supported by recent research using plasma proteomics and blood biomarkers to develop organ-specific aging clocks that predict disease risk and mortality 6 9 10 14.
- Blood-based proteomic clocks can identify accelerated aging in specific organs and predict organ-specific diseases (e.g., heart failure, Alzheimer's disease) 6 9.
- Machine learning models using common clinical blood panels can estimate biological age as accurately as more complex biomarker sets 10.
- Metabolomic age (MileAge) is associated with frailty, chronic illness, and shorter telomeres, supporting its use in risk stratification 14.
- These non-invasive approaches can help bring biological age assessment into routine clinical practice, as suggested by the new study's blood-based prediction model 10 13.
What are the clinical and research implications of measuring organ-specific aging?
Measuring the biological age of individual organs opens new possibilities for personalized medicine, early intervention, and aging research. The new study’s findings suggest that AI-driven tissue clocks and blood-based biomarkers could be used to monitor disease risk and progression, tailor interventions, and improve understanding of aging mechanisms. This is consistent with calls in the literature for composite aging measures and explainable AI tools to aid clinical decision-making 2 7 9 13.
- Early identification of accelerated aging in specific organs may enable targeted interventions to prevent or delay disease 2 7 8.
- Composite biological age scores, integrating molecular and physiological data, could provide a more comprehensive assessment of health and aging 7 9.
- AI and explainable models, such as ENABL Age, help clinicians interpret risk factors and mechanisms underlying aging, facilitating personalized care 13.
- Future research should focus on validating these measures in diverse populations and exploring interventions to slow organ-specific aging 2 7 13.
Future Research Questions
Further investigation is necessary to clarify how organ-specific biological aging influences disease risk, to refine non-invasive assessment methods, and to develop interventions that may slow aging processes. Below are several research questions that emerge from current findings and gaps in the literature:
| Research Question | Relevance |
|---|---|
| How do organ-specific biological age measures predict future disease risk and mortality? | Understanding these relationships could improve early detection and personalized intervention strategies, as multiple studies link advanced organ aging to higher disease risk and mortality 2 6 9. |
| Can blood-based biomarkers be used to reliably estimate biological age for all major organs? | If feasible, this would allow for non-invasive, routine monitoring of organ health, a key aim highlighted in both the current study and related research on blood-based clocks 6 10 13. |
| What are the underlying molecular mechanisms driving differential aging rates across organs? | Identifying these mechanisms could reveal targets for therapies to slow aging or treat age-related diseases, as suggested by multi-omics and aging network studies 2 9. |
| How do lifestyle, environmental, and genetic factors influence organ-specific biological aging? | Examining these factors can clarify why individuals experience divergent organ aging trajectories and inform prevention strategies, as highlighted by studies on lifestyle and environmental contributions to aging 2 8. |
| Can interventions such as diet, exercise, or pharmacological treatments modify the biological age of specific organs? | Investigating intervention effects on organ-specific aging could inform clinical recommendations and strategies to promote healthy longevity, a critical gap noted in both clinical and research contexts 7 8. |